Alterity Therapeutics Limited American Depositary Shares ATHE

$4.70 -4.28% at last close

Analyst Consensus

Consensus Rating
Buy (3 Buy · 1 Hold · 0 Sell)
Average Price Target
$12.67
Implied Upside
+169.5%
Price Target Range
$10.00 – $16.00
Analysts (12 mo)
4

Recent Analyst Actions

DateFirmActionRatingPrice Target
2026-08-11
Craig-HallumAdam Vogel
Initiates coverage on Buy $12
2026-06-30
Jones TradingDebanjana Chatterjee
Initiates coverage on Buy $16
2026-06-16
Ladenburg ThalmannCaroline Palomeque
Assumes Buy $10
2025-12-17
Canaccord Genuity
Initiates coverage on Speculative buy
2025-01-30
Maxim GroupJason McCarthy
Maintains Buy $8 → $12
2024-12-12
Maxim GroupJason McCarthy
Initiates coverage on Buy $8
2024-03-07
BenchmarkRobert Wasserman
Reiterates Speculative buy $4
2023-06-05
Ladenburg ThalmannAydin Huseynov
Maintains Buy $20 → $10
2022-08-03
Ladenburg ThalmannAydin Huseynov
Initiates coverage on Buy $20
2022-06-23
Goldman Sachs
Maintains Neutral $110 → $30
2021-08-20
BenchmarkAydin Huseynov
Initiates coverage on Speculative buy $40

Ratings and price targets reflect each firm's most recent published action. Consensus combines the latest call from every covering firm over the past 12 months; price targets are typically 12-month horizons.

Key Stats

Last Close
$4.70
Market Cap
$89.00 million
52-Week Range
$2.66 $7.00
Average Volume
12K shs

Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.